SECTOR GAMMA AS
Filing Date
Global Rank
#2,964
/ 8,633
▼ 15
Top Industry
Drug Manufacturers - General
25.8%
3Y Alpha vs SPY
-9.5%
Period ended 51 days ago
Filed Aug 12, 2026 · 8d
26 quarters · since Mar 2020
Clone Performance
Aug 2023–Aug 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+45.0%
SPY
+76.2%
Annualised alpha
-7.6%
Max drawdown
−12.9%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends; a captured split can shorten the simulated window. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
40 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
9.1%
−2.8 pts
Top 5
30.6%
−6.1 pts
Top 10
48.4%
−5.7 pts
HHI
370
Diversified−73
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $460,970,491 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | +210,685 | 906,088 | $8,970,271 | |
| ARDX | Ardelyx, Inc. | +170,713 | 686,844 | $3,502,904 | |
| QGEN | Qiagen N.V. | +125,269 | 287,640 | $11,246,724 | |
| GEHC | GE HealthCare Technologies Inc. | +81,445 | 207,863 | $13,305,310 | |
| MDT | Medtronic plc | +71,755 | 352,437 | $27,571,146 | |
| IOVA | Iovance Biotherapeutics, Inc. | +68,466 | 968,466 | $4,028,818 | |
| ABT | Abbott Laboratories | +59,912 | 147,444 | $13,379,068 | |
| BMRN | Biomarin Pharmaceutical Inc | +55,000 | 294,918 | $16,875,207 | |
| DXCM | Dexcom Inc | +46,000 | 102,122 | $6,877,916 | |
| IQV | Iqvia Holdings Inc. | +37,714 | 77,944 | $15,060,339 | |
| PTCT | Ptc Therapeutics, Inc. | +25,000 | 100,000 | $8,157,000 | |
| KURA | Kura Oncology, Inc. | +21,202 | 433,012 | $4,750,141 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +20,433 | 114,628 | $4,289,379 | |
| IONS | Ionis Pharmaceuticals Inc | +20,000 | 189,468 | $15,022,917 | |
| CVS | CVS HEALTH Corp | +20,000 | 155,337 | $16,069,612 | |
| BDX | Becton Dickinson & Co | +10,553 | 93,168 | $14,099,113 | |
| BIO | Bio-Rad Laboratories, Inc. | +9,600 | 33,350 | $9,791,893 | |
| LH | Labcorp Holdings Inc. | +7,000 | 26,019 | $7,285,320 | |
| ELV | Elevance Health, Inc. | +537 | 44,499 | $17,209,098 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OGN | Organon & Co. | −105,193 | 270,781 | $3,666,374 | |
| BMY | Bristol Myers Squibb Co | −101,786 | 726,115 | $41,838,746 | |
| BRKR | Bruker Corp | −101,658 | 152,352 | $9,168,543 | |
| PFE | Pfizer Inc | −87,170 | 1,004,215 | $24,181,497 | |
| SNDX | Syndax Pharmaceuticals Inc | −44,268 | 241,739 | $5,284,414 | |
| MRK | Merck & Co., Inc. | −43,332 | 217,008 | $27,885,528 | |
| BIIB | Biogen Inc. | −35,933 | 54,163 | $11,702,457 | |
| INCY | Incyte Corp | −29,757 | 170,753 | $19,356,560 | |
| AMGN | Amgen Inc | −20,874 | 26,281 | $9,516,875 | |
| CAH | Cardinal Health Inc | −14,208 | 40,689 | $9,666,078 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −13,528 | 142,307 | $12,251,209 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | 33,584 | $16,837,674 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,780 | $9,839,461 | |
| BSX | Boston Scientific Corp | 121,128 | $5,169,743 | |
| TVTX | Travere Therapeutics, Inc. | 80,000 | $4,544,800 | |
| CYTK | Cytokinetics Inc | 45,000 | $3,833,550 | |
| NTLA | Intellia Therapeutics, Inc. | 185,177 | $3,133,194 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| UNH | Unitedhealth Group Inc | 36,435 | $9,858,946 | |
| GILD | Gilead Sciences, Inc. | 53,247 | $7,421,034 | |
| LNTH | Lantheus Holdings, Inc. | 93,344 | $7,080,142 | |
| HUM | Humana Inc | 19,202 | $3,329,434 | |
| BBIO | BridgeBio Pharma, Inc. | 44,263 | $3,286,970 | |
| DNLI | Denali Therapeutics Inc. | 162,710 | $3,124,032 | |
| COGT | Cogent Biosciences, Inc. | 80,000 | $3,079,200 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 30,000 | $1,881,000 | |
| No positions match the current search. | ||||
40 tracked positions ·
$460,970,491 total
· filing declares
40 positions · $460,970,513
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 726,115 | $41,838,746 | 9.08% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Reduced | 217,008 | $27,885,528 | 6.05% | |
| MDT |
Medtronic plc
Healthcare
|
Added | 352,437 | $27,571,146 | 5.98% | |
| PFE |
Pfizer Inc
Healthcare
|
Reduced | 1,004,215 | $24,181,497 | 5.25% | |
| INCY |
Incyte Corp
Healthcare
|
Reduced | 170,753 | $19,356,560 | 4.20% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 44,499 | $17,209,098 | 3.73% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 294,918 | $16,875,207 | 3.66% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
NEW | 33,584 | $16,837,674 | 3.65% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Added | 155,337 | $16,069,612 | 3.49% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 77,944 | $15,060,339 | 3.27% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 189,468 | $15,022,917 | 3.26% | |
| BDX |
Becton Dickinson & Co
Healthcare
|
Added | 93,168 | $14,099,113 | 3.06% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 147,444 | $13,379,068 | 2.90% | |
| GEHC |
GE HealthCare Technologies Inc.
Healthcare
|
Added | 207,863 | $13,305,310 | 2.89% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Reduced | 142,307 | $12,251,209 | 2.66% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 54,163 | $11,702,457 | 2.54% | |
| QGEN |
Qiagen N.V.
Healthcare
|
Added | 287,640 | $11,246,724 | 2.44% | |
| CNC |
Centene Corp
Healthcare
|
Held | 162,405 | $10,424,776 | 2.26% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
NEW | 15,780 | $9,839,461 | 2.13% | |
| BIO |
Bio-Rad Laboratories, Inc.
Healthcare
|
Added | 33,350 | $9,791,893 | 2.12% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Reduced | 40,689 | $9,666,078 | 2.10% | |
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 26,281 | $9,516,875 | 2.06% | |
| BRKR |
Bruker Corp
Healthcare
|
Reduced | 152,352 | $9,168,543 | 1.99% | |
| AVTR |
Avantor, Inc.
Healthcare
|
Added | 906,088 | $8,970,271 | 1.95% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 100,000 | $8,157,000 | 1.77% | |
| LH |
Labcorp Holdings Inc.
Healthcare
|
Added | 26,019 | $7,285,320 | 1.58% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 102,122 | $6,877,916 | 1.49% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 21,305 | $5,682,469 | 1.23% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Held | 60,402 | $5,463,964 | 1.19% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 241,739 | $5,284,414 | 1.15% | |
| BSX |
Boston Scientific Corp
Healthcare
|
NEW | 121,128 | $5,169,743 | 1.12% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 433,012 | $4,750,141 | 1.03% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 80,000 | $4,544,800 | 0.99% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 114,628 | $4,289,379 | 0.93% | |
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
Held | 267,091 | $4,030,403 | 0.87% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Added | 968,466 | $4,028,818 | 0.87% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 45,000 | $3,833,550 | 0.83% | |
| OGN |
Organon & Co.
Healthcare
|
Reduced | 270,781 | $3,666,374 | 0.80% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Added | 686,844 | $3,502,904 | 0.76% | |
| NTLA |
Intellia Therapeutics, Inc.
Healthcare
|
NEW | 185,177 | $3,133,194 | 0.68% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.